Carbamazepine Tablets — Class II drug recall D-1317-2020
Terminated recall by Torrent Pharma Inc., reported 2020-06-10, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-1317-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Torrent Pharma Inc., Basking Ridge, NJ, United States |
| Recall initiated | 2020-05-11 |
| Classified | 2020-06-18 |
| Reported by FDA | 2020-06-10 |
| Terminated | 2022-08-10 |
| Distributed | Nationwide (US) |
| Quantity | 6,228 bottles |
| Reason classes | specification failure |
| NDC | 13668-0268, 13668-0268-01, 13668-0268-05, 13668-0268-10, 13668-0268-30, 13668-0268-31, 13668-0271, 13668-0271-01, 13668-0271-05, 13668-0271-10, 13668-0271-49 |
| Lot numbers | 4FF4F001 |
| Expiration dates | 2023-01 |
Product
Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1317-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.